4
Participants
Start Date
May 31, 2003
Primary Completion Date
July 31, 2004
Study Completion Date
July 31, 2004
bortezomib
docetaxel
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia
Duke Comprehensive Cancer Center, Durham
Veterans Affairs Medical Center - Atlanta (Decatur), Decatur
Winship Cancer Institute of Emory University, Atlanta
University of Miami Sylvester Cancer Center, Miami
Hubert H. Humphrey Cancer Center at North Memorial Medical Center, Robbinsdale
Siteman Cancer Center, St Louis
St. Louis University Hospital Cancer Center, St Louis
Kansas City Cancer Centers - Central, Kansas City
University of Texas - MD Anderson Cancer Center, Houston
University of Colorado Cancer Center at University of Colorado Health Sciences Center, Aurora
Huntsman Cancer Institute, Salt Lake City
Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center, Los Angeles
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham
Yale Comprehensive Cancer Center, New Haven
Massachusetts General Hospital Cancer Center, Boston
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston
Blumenthal Cancer Center at Carolinas Medical Center, Charlotte
Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center, Nashville
University of Wisconsin Comprehensive Cancer Center, Madison
National Cancer Institute (NCI)
NIH
University of Wisconsin, Madison
OTHER